Canntab Therapeutics Files 2 New Canadian Patent Applications Related to Pharmaceutical Cannabis
Toronto, Ontario--(Newsfile Corp. - May 25, 2018) - Canntab Therapeutics Limited (CSE: PILL) (formerly Telferscot Resources Inc.) ("Canntab" or the "Company") is pleased to announce that it continues to expand its extensive intellectual property portfolio through the recent filing of 2 additional Canadian patent applications. Canntab's portfolio now includes 13 patent applications in Canada, the United States and internationally. These filings build on Canntab's growing intellectual property...
2018-05-25 10:03 AM EDT
Canntab Appoints Bob Woloschuk to Advisory Board
Toronto, Ontario--(Newsfile Corp. - May 17, 2018) - Canntab Therapeutics Limited (CSE: PILL) ("Canntab" or the "Company") is pleased to announce the appointment of Bob Woloschuk to its Advisory Board. Bob has over 20 years of pharmaceutical executive experience and has a keen eye for licensing opportunities, both in Canada and in international markets.Jeff Renwick, Chief Executive Officer and a Director, commented "We are grateful for the opportunity to add someone of Bob's calibre to our...
2018-05-17 1:30 AM EDT
Canntab Provides Clarification on CFN Media Engagement
Toronto, Ontario--(Newsfile Corp. - May 15, 2018) - Canntab Therapeutics Limited (CSE: PILL) ("Canntab" or the "Company") wishes to provide clarification on the terms of its engagement of CFN Media Group ("CFN Media"), which were previously announced in a news release disseminated by CFN Media on May 15, 2018. Canntab wishes to clarify that CFN Media was engaged to provide investor relations services. The terms of the engagement require Canntab to pay CFN Media the amount of USD $5,000 per...
2018-05-15 5:37 PM EDT
Emblem and Canntab Therapeutics Announce Health Canada Approval for R&D of Cannabinoid-Based Oral Sustained Release Formulation
Paris, Ontario--(Newsfile Corp. - May 14, 2018) - Emblem Corp. (TSXV: EMC) (TSXV: EMC.WT) ("Emblem" or the "Company") and Canntab Therapeutics Limited (CSE: PILL) ("Canntab") are pleased announce to receipt of Health Canada approval for research and development activities on oral sustained release formulations of cannabinoids (the "Sustained Release Product" or the "Product"), which are the proprietary products conceived by Canntab representing significant progress in Emblem and Canntab's...
2018-05-14 9:21 AM EDT
Canntab Therapeutics Files 11 Patent Applications Related to Pharmaceutical Cannabis
Toronto, Ontario--(Newsfile Corp. - April 26, 2018) - Canntab Therapeutics Limited (CSE: PILL) (formerly Telferscot Resources Inc.) ("Canntab" or the "Company") is pleased to announce that it continues to expand its extensive intellectual property portfolio through the recent filing of 3 additional US patent applications and 1 international (Patent Cooperation Treaty or "PCT") application. Canntab's portfolio now includes 11 patent applications in the United States and internationally. These...
2018-04-26 9:00 AM EDT
Canntab Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - April 24, 2018) - Canntab Therapeutics Limited (CSE: PILL) ("Canntab" or the "Company") is pleased to announce two recent developments: (i) an update on its application for a Dealer's License with Health Canada; and (ii) its Australian joint venture partner has obtained a license to import medical cannabis products. Application for a Dealer's License with Health CanadaThe Company has engaged an experienced consultant for the purposes of finalizing and...
2018-04-24 9:44 AM EDT
Canntab to Commence Trading on CSE on 4/20
Toronto, Ontario--(Newsfile Corp. - April 19, 2018) - Canntab Therapeutics Limited (CSE: PILL) (formerly Telferscot Resources Inc.) ("Canntab" or the "Company") is pleased to announce that its common shares will commence trading on the Canadian Securities Exchange (the "CSE") at the opening of the market on Friday, April 20, 2018 under the stock symbol "PILL"."We are proud to announce that Canntab has joined the growing family of cannabis companies listed on the CSE, and believe that this...
2018-04-19 10:09 AM EDT
Canntab Therapeutics Announces Completion of Amalgamation with Telferscot Resources
Toronto, Ontario--(Newsfile Corp. - April 12, 2018) - Canntab Therapeutics Limited (formerly Telferscot Resources Inc.) (CSE:TFS) ("Canntab" or the "Company") is pleased to announce that it has closed its previously announced three-cornered amalgamation with Canntab Therapeutics Subsidiary Limited (formerly Canntab Therapeutics Limited) ("Canntab Private") and 2611780 Ontario Inc. ("261 Ontario"), a wholly owned subsidiary of the Company (the "Transaction"). The TransactionAs a part of the...
2018-04-12 8:50 PM EDT
CORRECTION FROM SOURCE: Telferscot to Distribute Equity in Seven New Companies to TFS Shareholders
Toronto, Ontario--(Newsfile Corp. - April 5, 2018) - Telferscot Resources Inc. (CSE: TFS) ("Telferscot" or the "Company") issues correction to April 3, 2018 release regarding figures for the shares distributed to Telferscot shareholders under the Company's Plan of Arrangement.Please see the following CORRECTED number of shares to be received by shareholders of Telferscot:For every 1,000 shares of Telferscot owned as of the Record Date (above), Telferscot shareholders will receive:100 shares...
2018-04-05 4:56 PM EDT
Telferscot Receives Final Approvals to Proceed with Acquisition of Canntab Therapeutics
Toronto, Ontario--(Newsfile Corp. - April 3, 2018) - Telferscot Resources Inc. (CSE: TFS) ("Telferscot" or the "Company") is pleased to announce that the Company has received confirmation from the Canadian Securities Exchange of approval of the listing of the common shares of Canntab Therapeutics Limited ("Canntab") subject to completion of the transactions as described in the listing statement and completion of any and all outstanding CSE documentation and fee payments.Additionally, the...
2018-04-03 12:49 PM EDT
Telferscot to Distribute Equity in Seven New Companies to TFS Shareholders
Toronto, Ontario--(Newsfile Corp. - April 3, 2018) - Telferscot Resources Inc. (CSE: TFS) ("Telferscot" or the "Company") is pleased to announce that the Company received final approval from the Ontario Superior Court for the Company's Plan of Arrangement. The Company has set a Record Date for the resulting distribution of shares of April 4, 2018.In addition to holding their shares of the Company, Telferscot shareholders will receive distributions in seven new companies (the "SpinCo" or...
2018-04-03 12:45 PM EDT
Telferscot Shareholders Approve Transactions
Toronto, Ontario--(Newsfile Corp. - March 23, 2018) - Telferscot Resources Inc. (CSE: TFS) ("Telferscot" or the "Company") is pleased to announce that the Company's shareholders have overwhelmingly approved the Plan of Arrangement and the Amalgamation Agreement facilitating the takeover of Canntab Therapeutics Limited (previously announced on January 15, March 1, 2018). 47.3% of TFS shares outstanding were voted at yesterday's meeting of Telferscot shareholders with a minimum of 98.46% of...
2018-03-23 12:56 PM EDT
Telferscot Shareholder Meeting and Canntab Acquisition Update
Toronto, Ontario--(Newsfile Corp. - March 1, 2018) - Telferscot Resources Inc. (CSE: TFS) ("Telferscot" or the "Company") is pleased to announce that the proxy materials to shareholders of Record as of February 16, 2018 have also been posted to SEDAR today. These materials include the Management Information Circular, which describes the terms of the acquisition of Canntab Therapeutics Limited and the plan of arrangement proposed be the Company to distribute the residual interests of the...
2018-03-01 3:32 PM EST